We reported that CD8+ T cells isolated from RCC patients exhibit defects in the JAK3/STAT5/6-signaling pathway, leading to T cell arrest in the G0/G1 phase of the cell cycle and prevention of their terminal differentiation [17]. The gene discussed is CD8A; the disease is renal cell carcinoma.